Arsenal 4.1

Manufacturer: Novartis (Farm Animal)

Bovine Rhinotracheitis - Virus Diarrhea - Parainfluenza 3 - Respiratory Syncytial Virus Vaccine

Modified Live Virus

For Use In Animals Only

Arsenal 4.1 Indications

For use in healthy non-pregnant cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI₃), and bovine respiratory syncytial (BRSV) viruses. When administered to cows and heifers 30 days prior to breeding, this product aids in the reduction of persistently infected calves caused by BVD Type 1 virus. This product contains non-cytopathic BVD Type 1 attenuated virus.

Directions

Aseptically rehydrate with liquid component supplied. Shake well before using. Administer 2 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Proven safe in calves 2 weeks of age or older. Calves vaccinated prior to 6 months of age should be revaccinated after 6 months of age. Revaccinate annually or as recommended by your veterinarian.

Precautions

Do not use in pregnant cows or in calves nursing pregnant cows. Store out of direct sunlight at 2°-7° C (35°-45° F). DO NOT FREEZE. Needles and syringes should not be sterilized with chemicals. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Burn this container and any unused contents. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B and gentamicin as preservatives.

U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2007 Novartis; Registered Trademark of Novartis AG

10 Doses	20 mL	250-01
50 Doses	100 mL	258-01

Nac No.

11140783